1009 related items for PubMed ID: 12224000
1. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[Abstract] [Full Text] [Related]
2. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
Kaya E, Erkurt MA, Aydogdu I, Kuku I, Ozhan O, Oner RI, Ulutas O.
Med Princ Pract; 2007 Aug; 16(2):100-6. PubMed ID: 17303943
[Abstract] [Full Text] [Related]
3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C, Castaman G, Rodeghiero F.
Haematologica; 1993 Aug; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[Abstract] [Full Text] [Related]
4. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ, Zhang L, Zhao H, Ji LX, Yang RC.
Chin Med J (Engl); 2005 Jan 05; 118(1):34-7. PubMed ID: 15642223
[Abstract] [Full Text] [Related]
5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
Am J Hematol; 2005 Apr 05; 78(4):275-80. PubMed ID: 15795920
[Abstract] [Full Text] [Related]
6. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB.
Am J Hematol; 2003 Feb 05; 72(2):94-8. PubMed ID: 12555211
[Abstract] [Full Text] [Related]
7. Outcome of chronic idiopathic thrombocytopenic purpura in children.
Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK.
Pediatr Blood Cancer; 2010 Mar 05; 54(3):403-7. PubMed ID: 19908301
[Abstract] [Full Text] [Related]
8. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
Haematologica; 2005 Jan 05; 90(1):72-7. PubMed ID: 15642672
[Abstract] [Full Text] [Related]
9. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J, Andrès E, Noel E, Koumarianou A, Blicklé JF, Maloisel F.
Clin Lab Haematol; 2004 Apr 05; 26(2):137-42. PubMed ID: 15053808
[Abstract] [Full Text] [Related]
10. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P, Busto MJ, Díez JL, Cabrera R, Regidor C, Forés R, Sanjuán I, Briz M, Fernández MN.
Sangre (Barc); 1995 Jun 05; 40(3):181-5. PubMed ID: 7570269
[Abstract] [Full Text] [Related]
11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C, Reu FJ, Ho AD, Hensel M.
Ann Hematol; 2007 Oct 05; 86(10):711-7. PubMed ID: 17622529
[Abstract] [Full Text] [Related]
12. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M, Sehon JK, White S, Zibari GB, Johnson LW.
Am Surg; 2000 Oct 05; 66(10):952-4; discussion 955. PubMed ID: 11261623
[Abstract] [Full Text] [Related]
13. Recurrent immune thrombocytopenic purpura in children.
Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.
Pediatr Hematol Oncol; 2006 Dec 05; 23(8):677-82. PubMed ID: 17065144
[Abstract] [Full Text] [Related]
14. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K, Gomi S, Kuramoto A, Maekawa T, Nomura T.
Int J Hematol; 1992 Jun 05; 55(3):287-92. PubMed ID: 1498319
[Abstract] [Full Text] [Related]
15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F.
Eur J Haematol Suppl; 2008 Feb 05; (69):19-26. PubMed ID: 18211569
[Abstract] [Full Text] [Related]
16. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Zhou H, Fu R, Wang H, Zhou F, Li H, Zhou Z, Zhang L, Yang R.
Ann Hematol; 2013 Jan 05; 92(1):79-87. PubMed ID: 22956151
[Abstract] [Full Text] [Related]
17. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri M, Dini E.
Haematologica; 1992 Jan 05; 77(3):248-52. PubMed ID: 1330848
[Abstract] [Full Text] [Related]
18. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
Aleem A.
Platelets; 2011 Jan 05; 22(1):1-7. PubMed ID: 20964585
[Abstract] [Full Text] [Related]
19. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM.
Platelets; 2008 Nov 05; 19(7):489-95. PubMed ID: 18979360
[Abstract] [Full Text] [Related]
20. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
Johansson E, Engervall P, Landgren O, Grimfors G, Widell S, Rezai S, Björkholm M.
Eur J Haematol; 2006 Jul 05; 77(1):61-6. PubMed ID: 16573739
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
